Alabaster (Diagnostic Equipment) Overview
- Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Alabaster (Diagnostic Equipment) General Information
Description
Developer of medical devices designed to decrease the risk of infection. The company's devices and equipment are used for biopsy procedures to decrease the risk of infection and improve efficiency, enabling patients to begin treatment quickly and resulting in an advanced likelihood of successful treatment.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
- Vancouver, British Columbia
- Canada
Alabaster (Diagnostic Equipment) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2016 | Completed | Stealth |
Alabaster (Diagnostic Equipment) Patents
Alabaster (Diagnostic Equipment) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2996350-A1 | Therapeutic agent delivering biopsy needle device and method of use | Inactive | 25-Aug-2015 | 0000000000 | |
| US-20170055901-A1 | Therapeutic agent delivering biopsy needle device and method of use | Inactive | 25-Aug-2015 | 0000000000 |
Alabaster (Diagnostic Equipment) Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Douglas Janzen | Northview Lifesciences | Board Member | 000 0000 |
Alabaster (Diagnostic Equipment) Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Northview Lifesciences | Venture Capital | Minority | 000 0000 | 000000 0 |